Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 2
2014 1
2016 1
2017 1
2019 1
2020 5
2021 8
2022 8
2023 6
2024 14
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry.
Brink M, Huisman F, Meeuwes FO, van der Poel MWM, Kersten MJ, Wondergem M, Böhmer L, Woei-A-Jin FJSH, Visser O, Oostvogels R, Jansen PM, Diepstra A, Snijders TJF, Huls G, Vermaat JSP, Plattel WJ, Nijland M. Brink M, et al. Among authors: plattel wj. Blood Adv. 2024 Jul 23;8(14):3619-3628. doi: 10.1182/bloodadvances.2023012531. Blood Adv. 2024. PMID: 38739705 Free PMC article.
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.
Federico M, Fortpied C, Stepanishyna Y, Gotti M, van der Maazen R, Cristinelli C, Re A, Plattel W, Lazarovici J, Merli F, Specht L, Schiano de Colella JM, Hutchings M, Versari A, Edeline V, Stamatoulas A, Girinsky T, Ricardi U, Aleman B, Meulemans B, Tonino S, Raemaekers J, André M. Federico M, et al. Among authors: plattel w. J Clin Oncol. 2024 Jan 1;42(1):19-25. doi: 10.1200/JCO.23.01745. Epub 2023 Nov 15. J Clin Oncol. 2024. PMID: 37967311 Free PMC article. Clinical Trial.
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium.
Kemps PG, Woei-A-Jin FJSH, Schöffski P, Tousseyn T, Vanden Bempt I, Meyer-Wentrup FAG, Dors N, van Eijkelenburg NKA, Scheijde-Vermeulen MA, Jazet IM, Limper M, Jak M, Verdijk RM, Donker ML, de Jonge NA, van Noesel CJM, Hebeda KM, van Dorp S, Tonino SH, van Laar JAM, van den Bos C, van Halteren AGS; HOVON Histiocytic and Lymphocytic Diseases Working Group. Kemps PG, et al. Blood Neoplasia. 2024 Jun 10;1(3):100023. doi: 10.1016/j.bneo.2024.100023. eCollection 2024 Sep. Blood Neoplasia. 2024. PMID: 40453055 Free PMC article.
Reply to T. Vassilakopoulos et al.
Federico M, Plattel W, Hutchings M, Stepanishyna Y, Fortpied C, André M. Federico M, et al. Among authors: plattel w. J Clin Oncol. 2024 Jun 20;42(18):2237-2238. doi: 10.1200/JCO.24.00143. Epub 2024 Apr 9. J Clin Oncol. 2024. PMID: 38593392 No abstract available.
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
Neppelenbroek SIM, Geurts YM, Aleman BMP, Lugtenburg PJ, Rademakers SE, de Weijer RJ, Schippers MGA, Ta BDP, Plattel WJ, Zijlstra JM, van der Maazen RWM, Nijziel MR, Ong F, Schimmel EC, Posthuma EFM, Kersten MJ, Böhmer LH, Muller K, Koene HR, Te Boome LCJ, Bilgin YM, de Jongh E, Janus CPM, van Leeuwen FE, Schaapveld M. Neppelenbroek SIM, et al. Among authors: plattel wj. J Clin Oncol. 2024 Jun 1;42(16):1903-1913. doi: 10.1200/JCO.23.01386. Epub 2024 Feb 15. J Clin Oncol. 2024. PMID: 38359378 Free PMC article.
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.
de Vries S, Schaapveld M, Janus CPM, Daniëls LA, Petersen EJ, van der Maazen RWM, Zijlstra JM, Beijert M, Nijziel MR, Verschueren KMS, Kremer LCM, van Eggermond AM, Lugtenburg PJ, Krol ADG, Roesink JM, Plattel WJ, van Spronsen DJ, van Imhoff GW, de Boer JP, Aleman BMP, van Leeuwen FE. de Vries S, et al. Among authors: plattel wj. J Natl Cancer Inst. 2021 Jun 1;113(6):760-769. doi: 10.1093/jnci/djaa194. J Natl Cancer Inst. 2021. PMID: 33351090 Free PMC article.
High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial.
Manuel G, Stepanishyna Y, Skrypets T, Marcheselli L, Cristinelli C, Botto B, Tonino S, Cavalieri D, Pulsoni A, Hutchings M, Hammoud M, Fortpied C, Rigacci L, Plattel W, André M, Federico M. Manuel G, et al. Among authors: plattel w. Hemasphere. 2025 Apr 2;9(4):e70105. doi: 10.1002/hem3.70105. eCollection 2025 Apr. Hemasphere. 2025. PMID: 40177617 Free PMC article. No abstract available.
51 results